DMD Phase 2 Results in Q4 = Potential 5000% Gem, page-210

Blockbuster I love your enthusiasm

But you really need to do more DD before you go spouting of it really does make you look foolish

Sounds good though

I have posted on more than one occasion that it had been mentioned on this forum that the Diamond has made it known that with the options converted and the backing of our two majors a figure of $10mill would take us through the ph2b and put it out there that we could take the drug to market 100 percent ANP owned
Like sarepta they would look at going to market direct after the ph2 b should the results be succcesful that is as there is such a need for treatment in the DMD space

But let's not run before we can walk here let's hope this initial trial brings us success

And a serious rerate

Personally if this trial does come good I would like to see them look towards a listing in the US would put us bang in the headlights, biotechs get much more support in the US and Goolsbee leading the charge don't think Diamonds up to it

Mathew Paul's made him look like a rank amateur last time around

Seeh we go